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Receptors for natriuretic peptides in a human cortical collecting duct
cell line. The aim of the present study was to analyze the expression of
natriuretic peptide receptors in human collecting duct, by using a newly
established SV4O cell line (HCD). ANP and C-type natriuretic peptide
(CNP) induced a concentration-dependent increase in cGMP suggesting
the presence of type-A (NPR-A) and type-B (NPR-B) receptors, respec-
tively. Threshold concentrations were I pt and I ntvi, respectively, and
stimulated over basal cGMP ratios were 500 and 160 at 0.1 !.LM ANP and
CNP. The urodilatin concentration-response curve was similar to that of
ANP. ['251J-ANP bound specifically to HCD cells in a time-dependent
fashion, reaching a plateau-phase between one and two hours at 4°C.
Equilibrium saturation binding curves suggested a single group of receptor
sites (Kd = 421 55 ptvt, = 49.2 8.8 fmol/mg protein, Hill
coefficient = 1.44 0.1, N = 6). Binding of ['251]-ANP was not displaced
by CNP or by C-ANP (4-23), a specific ligand of clearance receptors
(NPR-C), and thus occurred mainly via NPR-A. Neither Northern blot
analysis nor RT-PCR could detect NPR-C mRNA, although the latter was
clearly identified in control human glomerular visceral epithelial cells. In
contrast, PCR products with the expected lengths were obtained for
NPR-A and NPR-B. In conclusion, HCD cells express both NPR-A and
NPR-B, as demonstrated by mRNA and cGMP production studies, but
fail to produce NPR-C. This suggests that the human cortical collecting
duct is a target for ANP, CNP and urodilatin.
The natriuretic peptide system is a family of homologous
polypeptide hormones that stimulate diuresis, natriuresis, and
vasorelaxation [1]. It consists of at least three distinct endogenous
peptides: atrial natriuretic peptide (ANP), brain natriuretic pep-
tide (BNP), and C-type natriuretie peptide (CNP). All bind to
guanylate-cyclase coupled biological receptors (NPR-A and NPR-
B), but the affinity of ANP and BNP is much higher for NPR-A
while that of CNP is much higher for NPR-B [2]. In addition, the
three peptides hind to clearance receptors devoid of guanylate-
cyclasc activity (N PR-C) with a function that is currently poorly
defined [31.
ANP exerts multiple direct or indirect actions in the kidney that
lead to increases in glomerular filtration rate and excretion of
fluid and electrolytes. Its biological receptors (NPR-A) are local-
ized mainly in glomcrulus and inner medullary collecting duet by
various methods in rat [4—8] and bovine kidney [91. This suggests
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that in addition to its well-established effect on glomerular
filtration, ANP also modulates water and electrolyte transport in
the inner medullary collecting duct. Biological effects of ANP on
water and sodium transport have indeed been demonstrated by
Nonoguchi, Sands and Knepper [10] and Sands, Nonoguchi and
Knepper [11], respectively, in rat isolated perfused terminal
IMCDs. In the rat also, Terada et al [7] showed the presence of
NPR-A in the cortical part of the collecting duct using the
polymerase chain reaction coupled to reverse transcription (RT-
PCR), and Ritter et al [8] recently demonstrated NPR-A in thin
limbs of Henle's loop and in both principal and intercalated cells
of cortical collecting duets by immunocytochemistry. The renal
actions of CNP are much more controversial. Sudo et al [12] and
Tawaragi et al [131 found that intravenous injection of CNP
increased excretion of water and electrolytes. By contrast, Stingo
et al [14] reported a decrease in glomerular filtration rate, renal
blood flow, and urinary sodium flow and fractional excretion of
sodium, while Morita et al [15] did not find any significant effect
on renal fluid or electrolyte excretion after CNP infusion. In rat
cortical collecting duct, the restricted expression of NPR-B to the
apical pole of alpha intercalated cells [8] suggests the possibility
that CNP is involved in the regulation of bicarbonate transport in
this nephron segment. On the other hand, recent studies indicate
that CNP might act prominently as an autocrine/paracrine growth
factor: (i) Its renal production leading to urinary excretion [16]
was demonstrated by RT-PCR and/or immunohistochemistry in
mouse, rat and human distal tubule segments including cortical
collecting duct [16, 17]. (ii) CNP is a potent inhibitor of cell
growth in bovine aortic smooth muscle cells [18] and chondrocytes
[19].
In humans, the natriuretic effects of ANP at pharmacologic and
pathophysiologic doses [20] and the distribution and characteris-
tics of ANP receptors in glomerulus [21—231 are well established,
hut virtually nothing is known about the expression, type and
function of natriuretic peptide receptors in the collecting duct.
Only one study by Canaan-Kuhl et a! [24] identified NPR-A, -B
and -C by using RT-PCR in the human kidney, but their prepa-
ration contained glomeruli. Human studies are hampered by the
scarcity of starting material for microdissection followed by
RT-PCR, binding or cGMl' studies, and by the lack of human
tubule cell line derived from distal and collecting segments. We
have recently established by immortalization with Simian Virus-4()
(SV4O) a human cortical cell line that exhibits major properties of
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principal cells including high responsiveness to arginine-vasopres-
sin and lack of sensitivity to isoproterenol, parathyroid hormone
and calcitonin (in terms of cAMP production), and that expresses
CAM-Li, a basolatera) antigen specific for principal cells [25, 261.
Using this cell model, we now show that human collecting duct
principal cells express functional NPR-A and NPR-B and their
mRNA transcripts in the absence of significant amounts of
NPR-C. Therefore, the human cortical collecting duct may be a
target for both ANP and CNP acting as an hormone and an
autacoid, respectively.
Methods
Materials
The following radionuclides and reagents were obtained as
indicated: rat ANP-(1—28), C ANP-(4—23), porcine CNP-(1—22)
and [1251]-tyr°-CNP(37 TBq/mrnol) from Peninsula Laboratories
(Belmont, CA, USA); rat ['251]-tyr28-ANP-(1—28) (81.4 TBq/
mmol) and ['251]-cyclic GMP (81.4 TBq/mmol) from Dupont de
Nemours (Germany); anti-cyclic GMP antibody from Institut
Pasteur (Paris, France); oligo-dT primer and random primer from
Promega (Madison, WI, USA); dNTPs (2'-deoxynucleoside 5'-
triphosphate) and Taq DNA polymerase from Pharmacia LKB
Biotechnology (Uppsala, Sweden); Moloney murine leukemia
virus (MMLV) transcriptase reverse from Gibco BRL (Cergy
Pontoise, France); oligonucleotide primers (20 bases for each)
specific for NPR-A, -B, and -C were synthesized by Genset (Paris,
France). HS-142-1. a nonpeptide natriurctic peptide antagonist of
microbial origin, was a gift from Dr. Y. Matsuda (Tokyo, Japan).
Cell culture media and cell culture supplies were from Gibco
BRL. All other reagents were from Sigma (St. Louis, MO, USA).
Preparation of cells and characterization of natriuretic peptide
receptor proteins
Cell culture. isolation and characterization of the human col-
lecting duct cell line (HCD) were previously reported [25]. An
SV4O immortalized human podocyte cell line (HGVEC) was also
studied as a positive control for expression of NPR-C receptor
transcript [231. These cells were previously characterized and
shown to respond to ANP identically to the parental nontrans-
formed cells [27].
Both cell lines were grown in a hormonally defined medium
[DM; DMEM-HAM's F12, 1:1 (vol/vol); transferrin, 5 tg/ml;
sodium selenate. 50 mvi: glutamine, 2 mM; dexamethasone, 50 nM;
insulin, 5 rg/ml: Hepes, 20 mai, pH 7.4], supplemented with only
2% of newborn calf serum (NCS), in an atmosphere of 5%
C02--95% air, at 37°C. All experiments were performed between
passages 15 and 50, and 20 and 30 for HCI) and HGVEC,
respectively.
Determination of cyclic GMP production. At confluence, cells
grown in 12-well trays were preincuhated for 20 minutes at 37°C
in DM without NCS, hut containing 1 mrvi isohutylmethylxanthine
(IBMX), a phosphodiesterase inhibitor. The medium was aspi-
rated and cells were incubated during 15 minutes at 37°C with 0.5
ml of the same medium containing ANP, urodilatin or CNP at
final concentrations between 1 M and 0.1 jLM. Then the medium
was collected and the stimulation was stopped by adding 1 ml of
ice-cold ethanol 95%-formic acid 5% solution. After 30 minutes at
4°C, extracts were recovered, evaporated and stored at —20°C
with their corresponding media. The total cyclic GMP content was
measured by radioimmunoassay after resuspendirig the evapo-
rated intracellular fractions in 50 m sodium acetate buffer pH
6.2, and acetylating all the samples and the standards by a
triethylamine, acetic anhydre (2/1, vol/vol) solution.
The inhibitory effect of HS- 142-I, a nonpeptide ANP antagonist
[28], on the cyclic GMP response was studied at concentrations
between 0.1 and 100 j.tg/ml.
Binding studies. Human collecting duct cells grown to conflu-
ence in 12-well trays were rinsed twice with serum-free medium
and were incubated in 0.5 ml of DMEM-HAM's Fi2, 1:1 vol/vol,
containing 2 mg/ml bovine serum albumin (BSA), 1 mivi phenyl-
methylsulfonylfluoride, 2 mg/mI hacitracin, 1 mri EDTA, 10 /.LM
thiorphan, 1 tM aprotinin, I /SM leupeptin, 0.1 /.LM pepstatin, and
20 mM Hepes, in the presence of [1251]-ANP at 4°C in a room
atmosphere during four hours unless otherwise stated. At the end
of the incubation period, the medium was discarded and cells
were washed three or four times with I ml of ice-cold 0.16 M NaCI.
Then cells were solubilized with 1 M NaOH and cell-associated
radioactivity was counted in a LKB gamma automatic counter
with 65% efficiency. Specific binding was defined as the difference
between total binding and nonspecific binding obtained in the
presence of 1 .LM unlabeled ANP. In competitive inhibition
studies, unlabeled ANP, C ANP-(4—23), CNP, and urodilatin
were added at increasing concentrations from 1 M to 1 /.LM, and
HS-142-l was added at increasing concentrations from 1 to 100
tg/ml. Protein concentration in each well was determined by the
Bradford method using BSA as standard [29].
Identification of natriuretic peptide receptor transcripts by RT-PCR
and Northern blot analysis
RNA extraction and RT. Total RNA from cultured human
collecting duct and glomerular epithelial cells was prepared using
the guanidium thiocyanate method. RNA concentration and
purity were determined from the A260 and A28() readings. Total
RNA was then reverse-transcribed to first strand eDNA with
oligo-dT (15 mer) and random primer (6 mer) as previously
described [23].
PCR. One-fourth of the eDNA from the RT reaction was used
for amplification by PCR. Three pairs of primers specific for
human NPR-A, -B, and -C cDNAs were designed from the
published sequences [30—32] as previously reported [23]. The sizes
of the products between two primers are of 859 bp for NPR-A,
600 bp for NPR-B and 510 bp for NPR-C, respectively. PCR was
performed as previously described [23]. Amplification was carried
out by 30 or 40 cycles of denaturation (94°C, 1 mm), annealing
(55°C, 1 mm), and extension (72°C, 2 mm) using a DNA thermo-
cycler. One-tenth of the PCR products was controlled by electro-
phoresis in a 0.9% agarose gel.
DNA sequencing. Each PCR product amplified from NPR-A,
-B, and -C cDNAs was purified for sequencing as previously
described [231.
Northern blot. The NPR-C eDNA probe was provided by Dr. J.
Gordon Porter of Scios Nova (Mountain View, CA, USA) 131],
Total RNA from human collecting duct and glomerular epithelial
cell line (20 or 40 jig per lane) was fractionated by electrophoresis
in a 1.2% agarose gel and transferred to a nylon Gene Screen Plus
membrane (New England Nuclear, Boston, MA, USA). After
prehybridization, the blot was hybridized for 16 hours at 42°C with
the alpha [32P]-lahcled eDNA probe. The filter was then washed
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three times at 42°C for 20 minutes in 2 X SSC (1 X SSC is 0.15 M
NaC1 and 0.015 M sodium citrate, pH 7.0) containing 0.1% SDS,
colored with a 0.05% methylene-blue solution, and exposed to a
Fuji X-ray film at —80°C in the presence of an intensifying screen
for 48 hours.
Statistics
All experiments were performed two to six times in triplicate or
quadruplicate wells. Results are expressed as means SE. Com-
parisons between groups were analyzed with the use of Student's
t-test for unpaired values.
Results
Characterization of natriuretic peptide binding sites in human
collecting duct cells
Cyclic GMP production. Mean basal cyclic GMP levels were
0.823 0.085 pmol/mg protein (mean SE; N = 24). ANP,
urodilatin and CNP stimulated the production of cyclic GMP in a
concentration-dependent manner (Fig. 1) with a threshold con-
centration of 1 M for ANP and urodilatin (ANP, 5,12 0.90;
URO, 29.75 1.10 pmol/mg protein; P < 0.001) and of 1 ri for
CNP (2.60 0.15 pmol/mg protein; P < 0.001). Cyclic GMP
production did not reach a plateau in the range of ligand
concentrations tested up to 0.1 j.rM. At 0.1 /.LM concentration,
cyclic GMP was 5t)0, 450 and 160 times higher than its basal value
for ANP, urodilatin and CNP, respectively. HS-142-i, a novel
competitive nonpeptide antagonist of ANP binding to NPR-A and
NPR-B, reversed the stimulation by ANP and CNP of cyclic GMP
production in a concentration-dependent manner (0.1 to 100
j.rglml; Table 1). Seventy-five percent of CNP-stimulated cyclic
GMP was inhibited by 1 ig/ml of IIS-142-1, but only 55% of the
ANP-stimulated cyclic GMP was inhibited in the same cells at the
same antagonist concentration. At 10 j.tglml, HS-142-1 reduced
the cGMP response to both peptides by 93%.
HS-142-1
concentration
jig/mi
cGMP pmol/mg protein
ANPIO8M CNP5108M
0 444.50 57.00 55.70 5.40
0.1 408.50 39.00 24.62 3.15a
1 201.00 27.OOa 14.21 3.50'
10 32.00 390b 3.00 0.35'
50 5.10 067h 1.82 0.19k'
100 2.70 030b 1.91 024"
Means SE of 8 values (2 experiments) are shown. Results obtained in
the presence of HS-142-1 were compared to the stimulated values
measured in the absence of HS-142-1 using Student's t-test for unpaired
values. Basal (unstimulated) values of cGMP were 0.45 0.04 pmol/mg
protein.
ap < 0.01; hp < 0.001
8
Time, hours
Fig. 2. Time-course of total and specific binding of J'251J-ANP to human
collecting duct cells at 4°C. Total (0) and specific binding (•) were
measured during incubation with 50 pmol/liter ['251]-ANP. A representa-
tive experiment (N = 3) performed in triplicate wells is shown.
Binding studies. [1251]-ANP binding to collecting duct cells was
studied at 4°C as a function of time at a concentration of 50 pM.
As shown in Figure 2, binding rapidly increased within the first 30
minutes and reached a plateau between one and two hours.
Nonspecific binding represented —35% of total binding at equi-
librium. When the cells were incubated for four hours with
increasing concentrations of [1251J-ANP, the amount of bound
['251J-ANP followed a curvilinear ascending line (Fig. 3). The
Scatchard plot of the data (Fig. 4) was linear (r = 0.91), which
suggests the presence of a single group of ANP receptors. The
dissociation constant (Kd) and the number of sites (Bmax) derived
from six Scatchard analyses were 421 55 pmol/liter and 49.2
8.8 fmol/mg protein (7,000 sites per cell), respectively. Hill
equation (Fig. 4) allowed calculation of the n coefficient and of the
50% inhibitory concentration (lC,). n was 1.44 0.1. This value,
superior to unity, suggests a positive cooperative process of
['T]-ANP binding. IC50 was 104 10 pM.
When human collecting duct cells were incubated with 100 pi
1'2511-ANP for four hours at 4°C in the presence of increasing
concentrations of unlabeled ANP or urodilatin (1 M to 1 jiM),
competitive inhibition of binding was observed (Fig. 5). The
Table 1. Effect of HS-142-1 on ANP- and CNP-stimulated cyclic GMP
production in human collecting duct principal cells (HCD)500
400
3000
E0.
a:
200
0
100
0
Log concentration, M
Fig. 1. Cyclic GMP response of human collecting duct cells (HCD) to
increasing concentrations of AMP (S), URO (0) and CNP ), cGMP was
measured after a 15-minutes incubation. Means SE of 12 values for ANP
(4 experiments) and of 6 values for CNP and URO (2 experiments).
—12 —11 —10 —9 —8 —7
0
0
.0
a-z
U,
6
4
2
0
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inhibition curve rapidly decreased from 1 M to 10 nM ANP.
Concentration corresponding to 50% inhibition of total binding
(ED50) was —0.7 nM. Urodilatin, another natriuretic peptide
produced in the distal tubule segments of the kidney [33, 31,
inhibited [12511-ANP binding with a higher affinity (ED5() = 0.14
nM) than unlabeled ANP.
No inhibition of ['251j-ANP binding was obtained either with C
ANP-(4-23) or with CNP, suggesting the absence (or the presence
in very low amounts) of clearance receptors (NPR-C) in human
collecting duct cells. HS-142-1 at concentrations of 1, 10 and 100
jig/mi inhibited ['251]-ANP binding to the same extent as ANP did
at 0.01, 0.1 and 1 kM, respectively (data not shown).
It was not possible to demonstrate specific binding of [125J1
CNP to HCD cells, whereas ['2511-CNP bound in a time- and
concentration-dependent manner to isolated rat glomeruli incu-
bated with ['251]-CNP in parallel with HCD cells (data not
shown).
Characterization of natriuretic peptide receptor transcripts in
human collecting duct cells
RT-PCR identification of NPR-A, -B, and -C transcripts. eDNA
samples resulting from reverse transcription of 1.5 jig total RNA
from human collecting duct cells and epithelial glomerular cells as
positive control were subjected to 40 and 30 PCR cycles, respec-
tively. PCR products with the expected lengths were obtained for
NPR-A (859 bp) and NPR-B (600 bp) in both cell lines, but in
contrast with the glomerular cells, no signal of NPR-C amplifica-
tion product (510 hp) could he detected in the collecting duct cells
(Fig. 6). The signal for the NPR-B amplification transcript was
weaker than that of NPR-A.
Identification of NPR-C mRNA by Northern blot analysis. The
presence of specific NPR-C transcripts was also searched for in
human collecting duct and glomerular epithelial cells by Northern
blot analysis using a human cDNA probe. As shown in Figure 7,
Ln concentration, pM
Fig. 4. Scatchard (A, Kd 388 psI, B, = 55 finol/mg) and Hill
transformation (B; N 1.8, IC50 = 102pM) of the data. Same representa-
tive experiment as in Figure 3.
NPR-C mRNA could not be detected in collecting duct cells when
20 jig or 40 jig of total RNA were deposited, whereas in
glomcrular cells, a signal corresponding to NPR-C mRNA band
(4.8 kb) was clearly detected, increasing with the amount of
deposited RNA.
Discussion
Although the natriuretic effects of ANP are well-established in
humans at least at pharmacologic and pathophysiologic doses
[201, localization of NPR along the tubule is poorly defined. The
present study demonstrates that NPR-A and NPR-B, hut not
NPR-C, are expressed in a human cortical collecting duct cell line
whose characteristics arc close to those of the parental principal
cells in vivo. It strongly suggests, but does not prove NPR-A and
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Fig. 3. Specific binding of /'251J-ANP to human collecting duct cells at
equilibrium (4 hr) and at 4C as a function of /'251-tyi28/-ANP-(1-28)
concentration in medium. A representative experiment (N = 6) performed
in triplicate wells is shown.
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Fig. 5. Competitive inhibition of binding of ['251J-ANP to human collecting
duct cells at equilibrium (4 hr) and at 4cc, in the presence of increasing
concentrations of unlabeled .4NP (S), urodilatin (s), CNP (), and C-
ANP-(4-23) (). Means SE of 9 values (3 experiments) are shown for
ANP and C-ANP. Means SE of 6 values (2 experiments) are shown for
CNP and urodilatin.
Fig. 6. PCR products obtained after amplification of human collecting duct
cells and glomerular epithelial cells (HGVEC) eDNA. Amplification prod-
ucts specific for the three receptor subtypes (NPR-A, -B, and -C) were
detected in glomerular epithelial cells (HOVEC, right). Although in
collecting duct cells (HCD, left), identical amplification products were
obtained for NPR-A and NPR-B, no signal could be detected for NPR-C.
No signal was obtained when the RNA was omitted during the PCR
amplification (data not shown). Specificity of PCR products was previously
demonstrated by purification and sequencing [23]. A DNA molecular
weight ladder is shown for size determination (left lane).
NPR-B expression in the native human cortical collecting duct
because SV4O-transformed cells may acquire phenotypic differ-
ences from the cell of origin.
The assumption that human cortical collecting duct cells are
targets for ANP is based on the following grounds: (1) ['251]-ANP
binds to these cells with a high affinity (Kd = 421 55 pmol/liter);(2) ANP stimulates cyclic GMP production with a threshold
—
HGVEC HOD
Fig. 7. Northern blot analysis of total RNA from human glomerular epithe-
hal cells (HGVEC, left) and collecting duct cells (HCD, right) for expression
of NPR-C mRNA. For each cell type, two concentrations of total RNA
were applied: 20 pg (right lane) and 40 pg (left lane). Ethidium bromide
staining of 28 S and 18 S ribosomal RNA bands is shown (top) to confirm
that similar amounts of RNA were loaded for each cell type. Note the
absence of hybrization signal in HCD cells (bottom).
concentration of 1 pmol/liter; (3) NPR-A, but not NPR-C, mRNA
is expressed in HCD cells. These results indicate that cells from
the cortical segment of the human collecting duct are highly
responsive to ANP. In the renal tubule, NPR-A receptors have
been described mainly in the inner medullary collecting duet in ral
by ANP binding [4, 5] and cGMP stimulation studies [6], and by
RT-PCR of microdissected segments [7], as well as in ox by in situ
hybridization [9]. In the rat, NPR-A were also demonstrated in
the cortical segment of the collecting duct by RT-PCR [7].
Nonoguchi and coworkers first reported a small rise in cGMP
concentration in the rat cortical collecting duct in response to
ANP [6], and then demonstrated inhibition of salt and water
absorption by ANP across the perfused cortical collecting duct;
they suggested that much of the natriuresis of ANP infusion may
be attributable to this effect [35]. Tn rabbit, ANP inhibits the
action of vasopressin in perfused cortical collecting ducts [36]. Tn
humans, expression of NPR-A receptors is demonstrated in
glomerular epithelial cells, but their presence in tubule segments
remains to be established. The present data are in keeping with
the natriuretic effects of ANP in humans, which are not entirely
explained by its glomerular action [20]. HCD is the third cortical
collecting duct cell line expressing functional ANP receptors.
Stoos, Carretero and Garvin [371 first showed that ANP and
bradykinin synergistically inhibited transport in a mouse cortical
collecting duct cell line. We recently demonstrated the production
and the apically polarized extrusion of ANP-stimulated cGMP in
a rabbit collecting duct cell line transformed with a temperature-
sensitive strain of SV4O [38, 39]. Because production of cGMP in
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the rabbit cell line was maintained after SV40 large-T inactivation
at the nonpermissive temperature of 39.5°C, one can exclude that
ANP responsiveness in the human cell line was induced by SV4O
immortalization. The results obtained with our human and rabbit
cell lines as well as those of Ritter et al [8], who showed by
immunocytochemistry the expression of NPR-A in principal and
intercalated cells of the rat collecting duct, indicate that the
cortical collecting duct is a target for ANP. Our results also
suggest that it is a target for urodilatin that stimulates cGMP
production concentration-dependently and that inhibits with a
higher affinity than ANP, the binding of ['2511-ANP to NPR-A.
In addition to NPR-A receptors, HCD cells possess NPR-B
receptors: (1) CNP stimulates cyclic GMP production with a
threshold concentration of 1 nmol/liter; (2) NPR-B mRNA is
detected by RT-PCR amplification. We failed to demonstrate
specific binding of [1251]-CNP probably because of high hydrolytic
activity of HCD cells towards CNP, since the same radiolabeled
ligand specifically bound in a time- and concentration-dependent
fashion to human mesangial cells [23] and to isolated rat glomer-
uli incubated in parallel with HCD cells. In the rat collecting duct,
NPR-B receptors are restricted to the apical pole of alpha
intercalated cells by immunocytochemistry [8]. The expression of
NPR-B on HCD cells may be due to interspecies variation in the
distribution of NPR or to the cellular origin of the HCD cell line
that might be derived from a common ancestor to intercalated and
principal cells, as suggested by the expression of band-3, a marker
of alpha intercalated cells, in 100% of HCD cells [25]. Although
CNP markedly stimulated cGMP production, the threshold of
membrane guanylate cyclase stimulation was about 1,000 times
higher with CNP than with ANP. A similar difference between
ANP and CNP stimulation potencies was previously documented
in rat cortical collecting duct cells [40]. The reason why CNP has
less effect on cGMP accumulation than ANP in rat glomeruli,
arcuate artery, and renal tubules [401, as well as in human cortical
collecting duct cells is not known, and that could not be further
elucidated in the present study due to the failure of binding
studies. The presence of CNP in plasma is controversial [11. In any
case, its concentration is very low compared with that of ANP [41,
42] and with the threshold concentration determined in this study.
Therefore, if CNP acts as a circulating hormone, then it seems to
have no significant effects on human renal tubule function. On the
other hand, CNP mRNA and peptide have been demonstrated
by RT-PCR and immunohistochemistry in rat cortical collecting
duct [17] and by immunohistochemistry in human distal tubule
and medullary collecting duct as well as in human urine [16].
Urine immunoreactivity proved to be consistent by high pressure
liquid chromatography with both the low molecular weight form
CNP-22, as well as the high molecular weight form [16]. Hence,
renal collecting duct cells may be an additional non-vascular site
of synthesis of CNP that may act as an autacoid on the collecting
duct. Although CNP may represent the natriuretic peptide best
conserved throughout evolution, its action may not be limited to
regulation of natriuresis. The restricted expression of NPR-B on
rat alpha intercalated cells suggests a role of CNP in the regula-
tion of bicarbonate transport [81. Moreover, CNP has been shown
to modulate cell growth in various cell systems including bovine
aortic smooth muscle cells [181 and rat chondroeytes [19].
We failed to detect NPR-C in [lCD cells: (1) C ANP-(4-23), a
specific ligand of NPR-C, did not inhibit binding of ['251]-ANP to
HCD cells; (2) HS-142-1 (that does not bind NPR-C) inhibited
[1251]-ANP binding to the same extent as ANP (that does bind to
NPR-A and NPR-C); (3) NPR-C mRNA transcripts could not be
detected either by Northern blot or by RT-PCR of HCD cells
mRNA, although in parallel experiments those transcripts were
easily demonstrated in cultured human podocytes. The lack of
expression of NPR-C in HCD cells was unexpected since NPR-C
receptors usually increase dramatically in culture conditions [43,
44]. It was not due to SV4O tranfection since human podocytes
were immortalized with the same plasmid [27]. In the kidney,
NPR-C have been found thus far in bovine glomeruli [9] and in
human glomerular epithelial and mesangial cells [21—23], as well
as in rabbit renal cortical vascular smooth muscle cells [45], but to
our knowledge, they have never been demonstrated in tubule
segments by binding inhibition studies, immunohistochemistry,
RNAse protection assay, or in situ hybridization [DI. Because
NPR-C seem to act mainly as clearance receptors, one may
speculate that other factors including membrane hydrolases mod-
ulate binding of natriuretic peptides to the surface of collecting
duct cells. NPR-C occupancy by ANP can also inhibit cell
proliferation of rat astroglial cells [46] and aortic smooth muscle
cells [47]. Since the role of NPR-C remains debated, HCD cells
may represent an interesting tool to investigate its function by
transfecting the cells with the NPR-C eDNA.
In conclusion, we have demonstrated that human cortical
collecting duct cells express both NPR-A and NPR-B as shown by
mRNA and cGMP production studies, but fail to produce NPR-C.
These results strongly suggest that the human cortical collecting
duct is a target for ANP, CNP and urodilatin, but further studies
are needed to confirm these data in vivo. Since ANP (or urodila-
tin) and CNP both increase cGMP, their physiological specificity
remains to be defined.
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